{"id":832904,"date":"2025-04-02T08:40:14","date_gmt":"2025-04-02T12:40:14","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-8\/"},"modified":"2025-04-02T08:40:14","modified_gmt":"2025-04-02T12:40:14","slug":"immunocore-to-present-at-upcoming-investor-conferences-8","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-8\/","title":{"rendered":"Immunocore to present at upcoming investor conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"center\">Immunocore to present at upcoming investor conferences<\/p>\n<p align=\"justify\">(OXFORDSHIRE, England &amp; CONSHOHOCKEN, Penn. &amp; GAITHERSBURG, Md., US, 02 April 2025) <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=r-75tZY0SRyDgkqR0OOkGnh-5JBMcG-eyk-GSbIyt5PhcHo0vWmuOLmXcsJGHcJqIMiiW4rOh7Er2YRLnsfbCPihp2dd6-2yxH40Tin685mw9uJrVxkI2Jyo8ZvXEmgC7zMDfy392btENIAncZHGIUiKvjfwFjNaenBHqNV59f4KrHC3GLu9TeHUMbqGJhNQ\" rel=\"nofollow\" target=\"_blank\">Immunocore Holdings plc (Nasdaq: IMCR) (\u201cImmunocore\u201d or the \u201cCompany\u201d)<\/a>, a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases, today announced that management will participate in the following investor conferences in April.<\/p>\n<p align=\"justify\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<strong>Kempen Life Sciences Conference<\/strong><br \/>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a01&#215;1 and small group meetings: Thursday, April 3, 2025<\/p>\n<p align=\"justify\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<strong>Needham Virtual Healthcare Conference <\/strong><br \/>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Fireside Chat: Wednesday, April 9, 2025, at 2:15 p.m. EDT<\/p>\n<p align=\"justify\">Where relevant, the presentation will be webcast live and can be accessed by visiting \u2018Events &amp; Presentations\u2019, under \u2018Events\u2019, via the \u2018Investors\u2019 section of Immunocore\u2019s website at www.immunocore.com. Following the event, a replay of the presentations will be made available for a limited time.<\/p>\n<p align=\"justify\">\n        <strong>About Immunocore<\/strong>\n      <\/p>\n<p align=\"justify\">Immunocore is a commercial-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX \u2013 Immune mobilizing monoclonal TCRs Against X disease \u2013 designed to treat a broad range of diseases, including cancer, autoimmune, and infectious disease. Leveraging its proprietary, flexible, off-the-shelf ImmTAX platform, Immunocore is developing a deep pipeline in multiple therapeutic areas, including numerous active clinical and pre-clinical programs in oncology, infectious diseases, and autoimmune diseases. The Company\u2019s most advanced oncology TCR therapeutic, KIMMTRAK has been approved for the treatment of HLA-A*02:01-positive adult patients with unresectable or metastatic uveal melanoma in the United States, European Union, Canada, Australia, and the United Kingdom.<\/p>\n<p align=\"justify\">\n        <strong>Contact Information<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong>Immunocore <\/strong>\n      <\/p>\n<p align=\"justify\">S\u00e9bastien Desprez, VP Communications<br \/>T: +44 (0) 7458030732<br \/>E: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=AoH0T9Q4PhUkAH0GOX-6WtX52lPi-WgIzFtYemtXZOXqxtq_FRFAXakUB04A-_DAPFbkxC53Er8RvndF8upFsGnrcund_WfU1jpM9ltWfaGiwBXJKDxp2swILY87_m8gPvpJte3iDvBqsmuC0K2WyA==\" rel=\"nofollow\" target=\"_blank\"><u>sebastien.desprez@immunocore.com<\/u><\/a><br \/>Follow on LinkedIn: @Immunocore<\/p>\n<p align=\"justify\">\n        <strong>Investor Relations<\/strong>\n      <\/p>\n<p align=\"justify\">Clayton Robertson \/ Morgan Warenius<br \/>T: +1 (215) 384-4781<br \/>E: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=aaKaUts0HLT4Ee4r4xYWI2Q0t218zsKuYJOgv0gxtSejRE46QjgGtPkGJnHf7xh_1ZT1phfJ3hknFW2NYSDcHcRSUgOVh6acHgvqIsmcvlw=\" rel=\"nofollow\" target=\"_blank\"><u>ir@immunocore.com<\/u><\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA3NzYxNiM0MDIxMDYyOTMjMjIwNjI1OA==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/NGIxYzZkNGEtMWMyZC00MjhiLThmZjgtOTljMzg5ZWRjZThjLTEyMTc4MTEtMjAyNS0wNC0wMi1lbg==\/tiny\/Immunocore-Holdings-plc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Immunocore to present at upcoming investor conferences (OXFORDSHIRE, England &amp; CONSHOHOCKEN, Penn. &amp; GAITHERSBURG, Md., US, 02 April 2025) Immunocore Holdings plc (Nasdaq: IMCR) (\u201cImmunocore\u201d or the \u201cCompany\u201d), a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases, today announced that management will participate in the following investor conferences in April. \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Kempen Life Sciences Conference\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a01&#215;1 and small group meetings: Thursday, April 3, 2025 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Needham Virtual Healthcare Conference \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Fireside Chat: Wednesday, April 9, 2025, at 2:15 p.m. EDT Where relevant, the presentation will be webcast live and can be accessed by visiting \u2018Events &amp; Presentations\u2019, under \u2018Events\u2019, via the \u2018Investors\u2019 section of Immunocore\u2019s website at www.immunocore.com. Following the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-8\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Immunocore to present at upcoming investor conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-832904","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Immunocore to present at upcoming investor conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-8\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Immunocore to present at upcoming investor conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Immunocore to present at upcoming investor conferences (OXFORDSHIRE, England &amp; CONSHOHOCKEN, Penn. &amp; GAITHERSBURG, Md., US, 02 April 2025) Immunocore Holdings plc (Nasdaq: IMCR) (\u201cImmunocore\u201d or the \u201cCompany\u201d), a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases, today announced that management will participate in the following investor conferences in April. \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Kempen Life Sciences Conference\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a01&#215;1 and small group meetings: Thursday, April 3, 2025 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Needham Virtual Healthcare Conference \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Fireside Chat: Wednesday, April 9, 2025, at 2:15 p.m. EDT Where relevant, the presentation will be webcast live and can be accessed by visiting \u2018Events &amp; Presentations\u2019, under \u2018Events\u2019, via the \u2018Investors\u2019 section of Immunocore\u2019s website at www.immunocore.com. Following the &hellip; Continue reading &quot;Immunocore to present at upcoming investor conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-8\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-02T12:40:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA3NzYxNiM0MDIxMDYyOTMjMjIwNjI1OA==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-present-at-upcoming-investor-conferences-8\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-present-at-upcoming-investor-conferences-8\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Immunocore to present at upcoming investor conferences\",\"datePublished\":\"2025-04-02T12:40:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-present-at-upcoming-investor-conferences-8\\\/\"},\"wordCount\":278,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-present-at-upcoming-investor-conferences-8\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTA3NzYxNiM0MDIxMDYyOTMjMjIwNjI1OA==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-present-at-upcoming-investor-conferences-8\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-present-at-upcoming-investor-conferences-8\\\/\",\"name\":\"Immunocore to present at upcoming investor conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-present-at-upcoming-investor-conferences-8\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-present-at-upcoming-investor-conferences-8\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTA3NzYxNiM0MDIxMDYyOTMjMjIwNjI1OA==\",\"datePublished\":\"2025-04-02T12:40:14+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-present-at-upcoming-investor-conferences-8\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-present-at-upcoming-investor-conferences-8\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-present-at-upcoming-investor-conferences-8\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTA3NzYxNiM0MDIxMDYyOTMjMjIwNjI1OA==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTA3NzYxNiM0MDIxMDYyOTMjMjIwNjI1OA==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunocore-to-present-at-upcoming-investor-conferences-8\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Immunocore to present at upcoming investor conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Immunocore to present at upcoming investor conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-8\/","og_locale":"en_US","og_type":"article","og_title":"Immunocore to present at upcoming investor conferences - Market Newsdesk","og_description":"Immunocore to present at upcoming investor conferences (OXFORDSHIRE, England &amp; CONSHOHOCKEN, Penn. &amp; GAITHERSBURG, Md., US, 02 April 2025) Immunocore Holdings plc (Nasdaq: IMCR) (\u201cImmunocore\u201d or the \u201cCompany\u201d), a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases, today announced that management will participate in the following investor conferences in April. \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Kempen Life Sciences Conference\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a01&#215;1 and small group meetings: Thursday, April 3, 2025 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Needham Virtual Healthcare Conference \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Fireside Chat: Wednesday, April 9, 2025, at 2:15 p.m. EDT Where relevant, the presentation will be webcast live and can be accessed by visiting \u2018Events &amp; Presentations\u2019, under \u2018Events\u2019, via the \u2018Investors\u2019 section of Immunocore\u2019s website at www.immunocore.com. Following the &hellip; Continue reading \"Immunocore to present at upcoming investor conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-8\/","og_site_name":"Market Newsdesk","article_published_time":"2025-04-02T12:40:14+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA3NzYxNiM0MDIxMDYyOTMjMjIwNjI1OA==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-8\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-8\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Immunocore to present at upcoming investor conferences","datePublished":"2025-04-02T12:40:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-8\/"},"wordCount":278,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-8\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA3NzYxNiM0MDIxMDYyOTMjMjIwNjI1OA==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-8\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-8\/","name":"Immunocore to present at upcoming investor conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-8\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-8\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA3NzYxNiM0MDIxMDYyOTMjMjIwNjI1OA==","datePublished":"2025-04-02T12:40:14+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-8\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-8\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-8\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA3NzYxNiM0MDIxMDYyOTMjMjIwNjI1OA==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA3NzYxNiM0MDIxMDYyOTMjMjIwNjI1OA=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunocore-to-present-at-upcoming-investor-conferences-8\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Immunocore to present at upcoming investor conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/832904","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=832904"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/832904\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=832904"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=832904"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=832904"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}